2bve: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The Siglec family of receptors mediates cell-surface interactions through, recognition of sialylated glycoconjugates. Previously reported structures, of the N-terminal domain of the Siglec sialoadhesin (SnD1) in complex with, various sialic acid analogs revealed the structural template for sialic, acid binding. To characterize further the carbohydrate-binding properties, we have determined the crystal structures of SnD1 in the absence of, ligand, and in complex with 2-benzyl-Neu5NPro and 2-benzyl-Neu5NAc. These, structures reveal that SnD1 undergoes very few structural changes on, ligand binding and detail how two novel classes of sialic acid analogs, bind, one of which unexpectedly can induce Siglec dimerization. In, conjunction with in silico analysis, this set of structures informs us, about the design of putative ligands with enhanced binding affinities and, specificities to different Siglecs, and provides data with which to test, the effectiveness of different computational drug design protocols.
The Siglec family of receptors mediates cell-surface interactions through recognition of sialylated glycoconjugates. Previously reported structures of the N-terminal domain of the Siglec sialoadhesin (SnD1) in complex with various sialic acid analogs revealed the structural template for sialic acid binding. To characterize further the carbohydrate-binding properties, we have determined the crystal structures of SnD1 in the absence of ligand, and in complex with 2-benzyl-Neu5NPro and 2-benzyl-Neu5NAc. These structures reveal that SnD1 undergoes very few structural changes on ligand binding and detail how two novel classes of sialic acid analogs bind, one of which unexpectedly can induce Siglec dimerization. In conjunction with in silico analysis, this set of structures informs us about the design of putative ligands with enhanced binding affinities and specificities to different Siglecs, and provides data with which to test the effectiveness of different computational drug design protocols.


==About this Structure==
==About this Structure==
Line 14: Line 14:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Brossmer, R.]]
[[Category: Brossmer, R.]]
[[Category: Burtnick, L.D.]]
[[Category: Burtnick, L D.]]
[[Category: Crocker, P.]]
[[Category: Crocker, P.]]
[[Category: Jones, E.Y.]]
[[Category: Jones, E Y.]]
[[Category: Kelm, S.]]
[[Category: Kelm, S.]]
[[Category: May, A.P.]]
[[Category: May, A P.]]
[[Category: Robinson, R.C.]]
[[Category: Robinson, R C.]]
[[Category: Zaccai, N.R.]]
[[Category: Zaccai, N R.]]
[[Category: PH5]]
[[Category: PH5]]
[[Category: carbohydrate binding]]
[[Category: carbohydrate binding]]
Line 29: Line 29:
[[Category: siglec]]
[[Category: siglec]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 10:28:13 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:42:01 2008''

Revision as of 17:42, 21 February 2008

File:2bve.gif


2bve, resolution 2.20Å

Drag the structure with the mouse to rotate

STRUCTURE OF THE N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH 2-PHENYL-PROP5AC

OverviewOverview

The Siglec family of receptors mediates cell-surface interactions through recognition of sialylated glycoconjugates. Previously reported structures of the N-terminal domain of the Siglec sialoadhesin (SnD1) in complex with various sialic acid analogs revealed the structural template for sialic acid binding. To characterize further the carbohydrate-binding properties, we have determined the crystal structures of SnD1 in the absence of ligand, and in complex with 2-benzyl-Neu5NPro and 2-benzyl-Neu5NAc. These structures reveal that SnD1 undergoes very few structural changes on ligand binding and detail how two novel classes of sialic acid analogs bind, one of which unexpectedly can induce Siglec dimerization. In conjunction with in silico analysis, this set of structures informs us about the design of putative ligands with enhanced binding affinities and specificities to different Siglecs, and provides data with which to test the effectiveness of different computational drug design protocols.

About this StructureAbout this Structure

2BVE is a Single protein structure of sequence from Mus musculus with as ligand. Known structural/functional Site: . Full crystallographic information is available from OCA.

ReferenceReference

Crystallographic and in silico analysis of the sialoside-binding characteristics of the Siglec sialoadhesin., Zaccai NR, May AP, Robinson RC, Burtnick LD, Crocker PR, Brossmer R, Kelm S, Jones EY, J Mol Biol. 2007 Feb 2;365(5):1469-79. Epub 2006 Oct 28. PMID:17137591

Page seeded by OCA on Thu Feb 21 16:42:01 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA